Brinzolamide 1% ophthalmic suspension

DRUG6 trials

Sponsors

Alcon Research, Bausch & Lomb Incorporated, Padagis LLC

Conditions

GlaucomaGlaucoma, Open-AngleOcular HypertensionOpen Angle or Ocular HypertensionOpen-Angle Glaucoma

Phase 1

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

CompletedNCT03896633

Bausch & Lomb IncorporatedGlaucoma, Open Angle or Ocular Hypertension

Start: 2018-02-28End: 2018-11-17Updated: 2023-05-09

Phase 3

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

CompletedNCT01309204

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-05-31End: 2013-01-31Updated: 2014-04-07

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

CompletedNCT01310777

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-05-31End: 2013-01-31Updated: 2014-03-06

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01357616

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2010-11-30End: 2013-01-31Updated: 2014-04-10

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

CompletedNCT01722604

Bausch & Lomb IncorporatedGlaucoma, Open Angle or Ocular Hypertension

Start: 2012-01-31End: 2012-09-30Updated: 2023-05-09

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

CompletedNCT04024072

Padagis LLCGlaucoma, Open-Angle, Ocular Hypertension

Start: 2019-06-24End: 2020-04-30Updated: 2023-03-06